Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting FGF23-Klotho Signaling Axis

• Main Authors: Bu-Hui Liu (Author), Fee-Lan Chong (Author), Can-Can Yuan (Author), Ying-Lu Liu (Author), Hai-Ming Yang (Author), Wen-Wen Wang (Author), Qi-Jun Fang (Author), Wei Wu (Author), Mei-Zi Wang (Author), Yue Tu (Author), Zi-Yue Wan (Author), Yi-Gang Wan (Author), Guo-Wen Wu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD-MBD is very important in the clinic. In China, Fucoidan (FPS), a natural compound of Laminaria japoni...